Caption Management’s Achieve Life Sciences ACHV Stock Holding History

Caption Management’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.68M	Buy	1,175,500 +1,145,500	+3,818%	+$5.46M	0.04%	465
2026 Q1	$88.2K	Hold	30,000	–	–	﹤0.01%	1402
2025 Q4	$149K	Sell	30,000 -170,000	-85%	-$741K	﹤0.01%	1415
2025 Q3	$630K	Hold	200,000	–	–	﹤0.01%	1245
2025 Q2	$452K	Buy	+200,000	New	+$570K	0.01%	1132
2024 Q4	–	Sell	-41,400	Closed	-$196K	–	1426
2024 Q3	$196K	Sell	41,400 -66,300	-62%	-$303K	﹤0.01%	1067
2024 Q2	$506K	Buy	+107,700	New	+$519K	0.01%	807

Other funds holding ACHV

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Caption Management's ACHV Position: Q2 2026 in Review

Caption Management increased its Achieve Life Sciences (ACHV) stake by 164,924% in Q2 2026, buying an estimated $1.09M and bringing the position to 227,733 shares worth $1.49M. The position accounts for 0.01% of the portfolio, ranked #994.

Caption Management first reported a position in ACHV in Q4 2025 and has held it in 3 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

Caption Management held 227,733 shares of Achieve Life Sciences worth $1.49M as of Q2 2026.
Caption Management bought 227,595 Achieve Life Sciences shares in Q2 2026, an estimated $1.09M.
Achieve Life Sciences made up 0.01% of Caption Management's portfolio in Q2 2026, its #994 holding.
Caption Management first reported a position in Achieve Life Sciences in Q4 2025 and has held it in 3 quarters since.
111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.